Ebrahim Variava
2 ta ish
Perinatal HIV Research Unit
Bedaquiline–Pretomanid–Linezolid Regimens for Drug-Resistant Tuberculosis
Francesca Conradie, Tatevik R. Bagdasaryan, Borisov Se +25
MaqolaOchiq kirish20227 iqtibosABIEfficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pulmonary tuberculosis
Rodney Dawson, Andreas H. Diacon, Daniel E. Everitt +16
Maqola20152 iqtibosABI